Conceivable Life Sciences: pioneering the world’s first AI-powered automated IVF lab (AURA) to lower cost, increase access, and improve fertility outcomes.”
Location: United States, New York
Employees: 11-50
Total raised: $68M
Investors 1
| Date | Name | Website |
| - | ACME Capit... | acme.vc |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 16.09.2025 | Series A | $50M | - |
| 21.01.2025 | Series A | $18M | - |
Mentions in press and media 10
| Date | Title | Description |
| 07.07.2026 | ESHRE 42nd Annual Meeting: Halving fertility treatment costs could more than double births, major global study shows | A landmark international study has found that halving patient out-of-pocket costs was associated with a 2.67-fold increase in births achieved through assisted reproductive technology (ART). LONDON, July 7, 2026 /PRNewswire/ -- Presented at ... |
| 07.07.2026 | Halving IVF Out-of-Pocket Costs More Than Doubles Births: 22-Nation Study | By Mike Gonzales Published: Jul 07 2026, 2:18 PM EDT Share on Facebook Share on Twitter Share on LinkedIn Share on Reddit Share on Flipboard |
| 16.09.2025 | Conceivable Life Sciences Inks $50M Series A | NEW YORK, NY, Conceivable Life Sciences announced its $50 million Series A financing to accelerate the development and commercialization of its AI-powered automated IVF laboratory. >> Click here for more funding data on Conceivable L... |
| 15.09.2025 | Conceivable Life Sciences raises $50M in funding to bring robotic IVF embryo lab to US | For decades, in-vitro fertilization has relied on human hands and eyes—delicate, repetitive work that carries a high degree of variability. Conceivable Life Sciences wants to change that. The fertility tech startup just closed a $50 million... |
| 21.01.2025 | Conceivable Life Sciences: $18 Million (Series A) Raised For Advancing Development Of First AI-Based Automated IVF Lab | Conceivable Life Sciences, a biotech company revolutionizing the future of fertility care with the end-to-end automation of the IVF lab, announced the closing of an $18 million Series A financing. ARTIS Ventures led the round with participa... |
| 16.01.2025 | The Future of Fertility: Conceivable Life Sciences Revolutionizes IVF with AI and Robotics | In the bustling heart of New York City, a biotech company is reshaping the landscape of fertility care. Conceivable Life Sciences has just secured $18 million in Series A funding, bringing its total capital raised to over $39 million. This ... |
| 15.01.2025 | Conceivable Life Sciences Closes $18M Series A Financing | Conceivable Life Sciences, a NYC-based biotech company which specializes in fertility care, raised $18M in Series A funding. The round was led by ARTIS Ventures with participation from new investors including Atlantic Health Venture Studio,... |
| 14.01.2025 | Conceivable Life Sciences Closes $18 Million Series A Financing to Advance Development and Commercialization of the World’s First AI-Powered Automated IVF Lab | ARTIS Ventures led the financing with participation from new and existing investors, raising over $39 million to date Funds will support ongoing commercial pilot program in Mexico City and preparations for U.S. launch timed for early 2026 A... |
| - | Conceivable Life Sciences | “Conceivable Life Sciences” |
| - | Conceivable Life Sciences | “CONCEIVABLE Life Sciences | A New Kind of IVF” |